Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinoma
Emeline Guiard, Florian Clatot, Caroline Even, Marion Perréard, Cyril Abdeddaim, Alison Johnson, Élodie Vauléon, Audrey Rambeau
Topics & Concepts
NivolumabMedicineTaxaneInternal medicineOncologyHead and neck squamous-cell carcinomaProgression-free survivalHead and neck cancerChemotherapyCancerImmunotherapyBreast cancerHead and Neck Cancer StudiesCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses